Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Long-Term Romiplostim Use for Refractory Aplastic Anemia

Blood (2022) 140 (Supplement 1): 8634–8637.

https://doi.org/10.1182/blood-2022-162895

Published: 2022

Journal Articles

Overall Survival in Acquired Pure Red Cell Aplasia in Adults Following Immunosuppressive Therapy: Preliminary Results from the Nationwide Cohort Study (PRCA2016)

Naohito Fujishima, MD, Makoto Hirokawa, MD PhD, Kenichi Sawada, MD, Shinji Nakao, MD PhD, Yuji Yonemura, MD PhD, Akira Matsuda, MD, Norio Komatsu, MD PhD, Hideo Harigae, MD, Akiko Saito, MD, Kaoru Tohyama, MD, Itaru Matsumura, MD, Mineo Kurokawa, MD PhD, Shunya Arai, MD PhD, Kinuko Mitani, MD

Blood (2018) 132 (Supplement 1): 2593.

https://doi.org/10.1182/blood-2018-99-114245

Published: 2018

Journal Articles

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Makoto Hirokawa, MD PhD, Junki Kohmaru, Souichi Koyota, PhD, Keiji Kuba, MD, Naohito Fujishima, MD, Tomoo Saga, MD, Ayumi Omokawa, MD, Shigeharu Ueki, MD, Fumihiro Ishida, MD FACP, Shinji Nakao, MD PhD, Akira Matsuda, MD, Akiko Ohta, MD, Kaoru Tohyama, MD, Ryuji Suzuki, DVM, PhD, Kinuko Mitani, MD

Blood (2018) 132 (Supplement 1): 3858.

https://doi.org/10.1182/blood-2018-99-113262

Published: 2018

Journal Articles

Efficacy and Safety of Romiplostim in Patients with Acquired Aplastic Anemia Ineligible or Refractory to Immunosuppressive Therapy: Interim Analysis of Phase 2/3 Clinical Trial

Blood (2018) 132 (Supplement 1): 1306.

https://doi.org/10.1182/blood-2018-99-112478

Published: 2018

Journal Articles

Identification of Adverse Risk Factors for Survival in Acquired Pure Red Cell Aplasia Receiving Immunosuppressive Therapy By the Japan PRCA2004/2006 Study and Introduction to the New Cohort Study PRCA2016

Blood (2017) 130 (Supplement 1): 4954.

https://doi.org/10.1182/blood.V130.Suppl_1.4954.4954

Published: 2017

Journal Articles

Association of Increased Ring Ssideroblasts with Inferior Survival in Patients with Myelodysplastic Syndrome with Multi-Lineage Dysplasia

Hiroshi Kawabata, MD PhD, Kaoru Tohyama, MD PhD, Akira Matsuda, MD PhD, Kayano Araseki, MD PhD, Tomoko Hata, MD PhD, Takahiro Suzuki, MD, PhD, Hidekazu Kayano, MD PhD, Kei Shinbo, MT, Kensuke Usuki, MD PhD, Akira Hangaishi, MD PhD, Shigeru Chiba, MD, PhD, Nogawa Masaharu, MD PhD, Nobuyoshi Arima, MD PhD, Takayuki Ishikawa, MD PhD, Keiya Ozawa, MD PhD, Shunya Arai, MD, PhD, Mineo Kurokawa, MD, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 5530.

https://doi.org/10.1182/blood.V128.22.5530.5530

Published: 2016

Journal Articles

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

Sumiko Kobayashi, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Kiyoyuki Ogata, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kensuke Usuki, MD, PhD, Kazuma Ohyashiki, MD, PhD, Keiya Ozawa, MD, PhD, Yasushi Miyazaki, MD, PhD, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD

Blood (2013) 122 (21): 2795.

https://doi.org/10.1182/blood.V122.21.2795.2795

Published: 2013

Journal Articles

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Yasuko Hamada, MD, Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Namiko Okuyama, MD, Asaka Kondo, MD, PhD, Keiichi Moriya, MD, PhD, Kiyoyuki Ogata, MD, PhD, Keiji Kakumoto, Yoshihide Miyazaki, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2799.

https://doi.org/10.1182/blood.V122.21.2799.2799

Published: 2013

Journal Articles

Homologous Recombination Repair of DNA Strand Breaks Induced by the Nucleoside Analogue CNDAG.

Xiaojun Liu, Ph.D., Yingjun Jiang, Ph.D., Akira Matsuda, Ph.D., William Plunkett, PhD

Blood (2010) 116 (21): 1189.

https://doi.org/10.1182/blood.V116.21.1189.1189

Published: 2010

Journal Articles

Differences In Clinical Characteristics and Prognostic Features Between Patients with Myelodysplastic Syndromes (MDS) From Korea, Japan, and Germany

Andrea Kuendgen, Je-Hwan Lee, Akira Matsuda, Kyoo Hyung Lee, Jung-Hee Lee, Norbert Gattermann, MD, PhD, Rainer Haas, Ulrich Germing

Blood (2010) 116 (21): 1882.

https://doi.org/10.1182/blood.V116.21.1882.1882

Published: 2010

Journal Articles

Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC

Xiaojun Liu, Yaqing Wang, Sherri Benaissa, Akira Matsuda, Hagop Kantarjian, Zeev Estrov, William Plunkett

Blood (2010) 116 (10): 1737–1746.

https://doi.org/10.1182/blood-2009-05-220376

Published: 2010

Includes: Supplemental data

Journal Articles

Serum Erythropoietin Dose Not Participate in Anemia That Persists in CML Patients after MMR Achievement by Imatinib Mesylate Therapy

Maho Ishikawa, MD, PhD, Fumiharu Yagasaki, MD, PhD, Daisuke Okamura, MD, Tomoya Maeda, MD, PhD, Naoki Takahashi, MD, PhD, Nobutaka Kawai, MD, PhD, Akira Matsuda, MD, PhD, Itsuro Jinnai, MD, PhD, Masami Bessho, MD, PhD

Blood (2008) 112 (11): 4274.

https://doi.org/10.1182/blood.V112.11.4274.4274

Published: 2008

Journal Articles

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes: A Prospective Validation Study in Low-Risk Patients with Normal Karyotype

Kiyoyuki Ogata, Matteo G. Della Porta, Luca Malcovati, Cristina Picone, Norio Yokose, Akira Matsuda, Taishi Yamashita, Hideto Tamura, Junichi Tsukada, Kazuo Dan, Mario Cazzola

Blood (2008) 112 (11): 3634.

https://doi.org/10.1182/blood.V112.11.3634.3634

Published: 2008

Journal Articles

Responses and Outcome Following Immunosuppressive Therapy in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.

Naohito Fujishima, Ken-ichi Sawada, Makoto Hirokawa, Kazuo Oshimi, Akira Matsuda, Masanao Teramura, Masamitsu Karasawa, Shinji Nakao, Akio Urabe, Mitsuhiro Omine, Keiya Ozawa

Blood (2007) 110 (11): 1688.

https://doi.org/10.1182/blood.V110.11.1688.1688

Published: 2007

Journal Articles

Expression of ERK1/ERK2 MAP Kinase, Protein Kinase C and Akt Kinase by Lymphoid Malignant Cells.

Ikuo Murohashi, MD, Takashi Takahashi, MD, Noriko Ihara, MS, Daisuke Wakao, MD, Fumiharu Yagasaki, MD, Yhuichi Nakamura, MD, Nobutaka Kawai, MD, Akira Matsuda, MD, Itsuro Jinnai, MD, Masami Bessho, MD

Blood (2005) 106 (11): 4391.

https://doi.org/10.1182/blood.V106.11.4391.4391

Published: 2005

Journal Articles

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

Akira Matsuda, Ulrich Germing, Itsuro Jinnai, Motohiro Misumi, Andrea Kuendgen, Sabine Knipp, Manuel Aivado, Masako Iwanaga, Yasushi Miyazaki, Hideki Tsushima, Mari Sakai, Masami Bessho, Masao Tomonaga

Blood (2005) 106 (8): 2633–2640.

https://doi.org/10.1182/blood-2005-01-0040

Published: 2005

Journal Articles

A Novel Fusion, KIAA0379 (Ankyrin Repeat Domain 28) to NUP98 in an Adult MDS/AML with a t(3;5;11)(p25;q35;p15).

Maho Ishikawa, Fumiharu Yagasaki, Daisuke Okamura, Tomoya Maeda, Yuichi Sugahara, Motohiro Misumi, Katsuhiko Yoshida, Yuichi Nakamura, Nobutaka Kawai, Akira Matsuda, Itsuro Jinnai, Masami Bessho

Blood (2004) 104 (11): 4278.

https://doi.org/10.1182/blood.V104.11.4278.4278

Published: 2004

NARROW

Efficacy and Safety of Long-Term Romiplostim Use for Refractory Aplastic Anemia

Overall Survival in Acquired Pure Red Cell Aplasia in Adults Following Immunosuppressive Therapy: Preliminary Results from the Nationwide Cohort Study (PRCA2016)

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Efficacy and Safety of Romiplostim in Patients with Acquired Aplastic Anemia Ineligible or Refractory to Immunosuppressive Therapy: Interim Analysis of Phase 2/3 Clinical Trial

Identification of Adverse Risk Factors for Survival in Acquired Pure Red Cell Aplasia Receiving Immunosuppressive Therapy By the Japan PRCA2004/2006 Study and Introduction to the New Cohort Study PRCA2016

Association of Increased Ring Ssideroblasts with Inferior Survival in Patients with Myelodysplastic Syndrome with Multi-Lineage Dysplasia

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Homologous Recombination Repair of DNA Strand Breaks Induced by the Nucleoside Analogue CNDAG.

Differences In Clinical Characteristics and Prognostic Features Between Patients with Myelodysplastic Syndromes (MDS) From Korea, Japan, and Germany

Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC

Serum Erythropoietin Dose Not Participate in Anemia That Persists in CML Patients after MMR Achievement by Imatinib Mesylate Therapy

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes: A Prospective Validation Study in Low-Risk Patients with Normal Karyotype

Responses and Outcome Following Immunosuppressive Therapy in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.

Expression of ERK1/ERK2 MAP Kinase, Protein Kinase C and Akt Kinase by Lymphoid Malignant Cells.

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

A Novel Fusion, KIAA0379 (Ankyrin Repeat Domain 28) to NUP98 in an Adult MDS/AML with a t(3;5;11)(p25;q35;p15).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only